Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2000 1
2001 1
2003 3
2005 2
2006 3
2007 4
2008 6
2009 6
2010 9
2011 13
2012 21
2013 7
2014 5
2015 8
2016 6
2017 5
2018 10
2019 9
2020 14
2021 14
2022 11
2023 13
2024 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

159 results

Results by year

Filters applied: . Clear all
Page 1
Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial.
Male C, Lensing AWA, Palumbo JS, Kumar R, Nurmeev I, Hege K, Bonnet D, Connor P, Hooimeijer HL, Torres M, Chan AKC, Kenet G, Holzhauer S, Santamaría A, Amedro P, Chalmers E, Simioni P, Bhat RV, Yee DL, Lvova O, Beyer-Westendorf J, Biss TT, Martinelli I, Saracco P, Peters M, Kállay K, Gauger CA, Massicotte MP, Young G, Pap AF, Majumder M, Smith WT, Heubach JF, Berkowitz SD, Thelen K, Kubitza D, Crowther M, Prins MH, Monagle P; EINSTEIN-Jr Phase 3 Investigators. Male C, et al. Lancet Haematol. 2020 Jan;7(1):e18-e27. doi: 10.1016/S2352-3026(19)30219-4. Epub 2019 Nov 5. Lancet Haematol. 2020. PMID: 31699660 Free article. Clinical Trial.
Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT Randomized Clinical Trial.
Goldenberg NA, Kittelson JM, Abshire TC, Bonaca M, Casella JF, Dale RA, Halperin JL, Hamblin F, Kessler CM, Manco-Johnson MJ, Sidonio RF, Spyropoulos AC, Steg PG, Turpie AGG, Schulman S; Kids-DOTT Trial Investigators and the ATLAS Group. Goldenberg NA, et al. JAMA. 2022 Jan 11;327(2):129-137. doi: 10.1001/jama.2021.23182. JAMA. 2022. PMID: 35015038 Free PMC article. Clinical Trial.
Treatment adherence in hemophilia.
Thornburg CD, Duncan NA. Thornburg CD, et al. Patient Prefer Adherence. 2017 Sep 27;11:1677-1686. doi: 10.2147/PPA.S139851. eCollection 2017. Patient Prefer Adherence. 2017. PMID: 29033555 Free PMC article. Review.
Creating and screening natural product libraries.
Wilson BAP, Thornburg CC, Henrich CJ, Grkovic T, O'Keefe BR. Wilson BAP, et al. Among authors: thornburg cc. Nat Prod Rep. 2020 Jul 1;37(7):893-918. doi: 10.1039/c9np00068b. Epub 2020 Mar 18. Nat Prod Rep. 2020. PMID: 32186299 Free PMC article. Review.
Prepare the Way for Hemophilia A Gene Therapy.
Thornburg CD. Thornburg CD. N Engl J Med. 2022 Mar 17;386(11):1081-1082. doi: 10.1056/NEJMe2200878. N Engl J Med. 2022. PMID: 35294817 No abstract available.
How we approach: Training pediatric coagulationists.
Thornburg CD, Montgomery RR, Pipe SW. Thornburg CD, et al. Pediatr Blood Cancer. 2019 Dec;66(12):e27982. doi: 10.1002/pbc.27982. Epub 2019 Sep 5. Pediatr Blood Cancer. 2019. PMID: 31486588 Review.
Travelers with sickle cell disease.
Willen SM, Thornburg CD, Lantos PM. Willen SM, et al. Among authors: thornburg cd. J Travel Med. 2014 Sep-Oct;21(5):332-9. doi: 10.1111/jtm.12142. Epub 2014 Jun 19. J Travel Med. 2014. PMID: 24947546 Free PMC article. Review.
159 results